Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Muhannad Abu-Remaileh, Ph.D.

Concepts (74)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Muhannad Abu-Remaileh's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Muhannad Abu-Remaileh has written about over time.
Oxidoreductases, 5 publications between 2013 and 2015, average publication date September 2014. Cells, 1 publications between 2014 and 2014, average publication date December 2014. Neoplasms, 3 publications between 2014 and 2015, average publication date February 2015. Central Nervous System, 1 publications between 2015 and 2015, average publication date October 2015. Mice, Knockout, 5 publications between 2013 and 2019, average publication date January 2016. Tumor Suppressor Proteins, 7 publications between 2013 and 2022, average publication date May 2016. Glucose, 2 publications between 2014 and 2019, average publication date January 2017. Genes, Tumor Suppressor, 2 publications between 2013 and 2022, average publication date March 2018. Carcinoma, Hepatocellular, 1 publications between 2018 and 2018, average publication date April 2018. Diethylnitrosamine, 1 publications between 2018 and 2018, average publication date April 2018. Gene Expression Regulation, Neoplastic, 1 publications between 2018 and 2018, average publication date April 2018. Hypoxia-Inducible Factor 1, alpha Subunit, 1 publications between 2018 and 2018, average publication date April 2018. Liver Neoplasms, 1 publications between 2018 and 2018, average publication date April 2018. Carbohydrate Metabolism, 1 publications between 2019 and 2019, average publication date January 2019. Basic Helix-Loop-Helix Transcription Factors, 1 publications between 2024 and 2024, average publication date September 2024. Neuroendocrine Tumors, 1 publications between 2024 and 2024, average publication date September 2024. Paraganglioma, 1 publications between 2024 and 2024, average publication date September 2024. von Hippel-Lindau Disease, 1 publications between 2024 and 2024, average publication date September 2024. Von Hippel-Lindau Tumor Suppressor Protein, 1 publications between 2024 and 2024, average publication date September 2024.

To see the data from this visualization as text, click here.
Abu-Remaileh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (74)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.